Mineralys Therapeutics, Inc. - Common Stock (MLYS)

200 filings reported holding MLYS - Mineralys Therapeutics, Inc. - Common Stock as of Q2 2025.
Mineralys Therapeutics, Inc. - Common Stock (MLYS) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 65,687,280 shares of 77,392,610 outstanding shares and own 85% of the company stock.
Largest 10 shareholders include Catalys Pacific, LLC (8,903,838 shares), RA CAPITAL MANAGEMENT, L.P. (6,147,280 shares), SAMSARA BIOCAPITAL, LLC (5,674,916 shares), SR One Capital Management, LP (3,127,933 shares), BlackRock, Inc. (3,097,760 shares), Capital International Investors (2,899,020 shares), Integral Health Asset Management, LLC (2,700,000 shares), VANGUARD GROUP INC (2,326,449 shares), Caligan Partners LP (2,017,352 shares), and FRANKLIN RESOURCES INC (1,803,597 shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.